Anatomic TSA vs RTSA for Glenohumeral Arthritis
ConditionArthritis Shoulder
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-85
SponsorLa Tour Hospital
About this trial
There are no published prospective studies that compared 2-year functional outcomes of RTSA and anatomic TSA for the treatment of primary glenohumeral osteoarthritis with intact rotator cuffs and no excessive glenoid retroversion. The primary goal of our prospective randomized study is to determine whether RTSA have at least as good results as anatomic TSA (non-inferiority), in patients with glenohumeral osteoarthritis, without rotator cuff tears nor significant glenoid retroversion.
Eligibility criteria
Qualifiers
Primary glenohumeral arthritis,
Intact rotator cuff,
No important glenoid bone loss (cf
Disqualifiers
Patients between 65 and 85 years old
Informed Consent as documented by signature (Appendix Informed Consent Form).
B2 glenoid with > 80% posterior humeral head subluxation or greater 25 degrees neoglenoid retroversion,
B3 and C type glenoids,
Trial design
Treatments tested in this trial
- Total shoulder arthroplasty
Treatment groups
296 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov